

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.67157900 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.67157900 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.33300449 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.33300449 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.97256476 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.91249542 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.42592669 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.42592669 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.42592669 |
| 10 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 5.37888765 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.35232225 |
| 12 | tyrosine metabolic process (GO:0006570) | 5.33643054 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.31761879 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.29766912 |
| 15 | urea metabolic process (GO:0019627) | 5.27922720 |
| 16 | urea cycle (GO:0000050) | 5.27922720 |
| 17 | regulation of gene silencing by RNA (GO:0060966) | 5.26660559 |
| 18 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.26660559 |
| 19 | regulation of gene silencing by miRNA (GO:0060964) | 5.26660559 |
| 20 | complement activation, alternative pathway (GO:0006957) | 5.21317659 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.17333275 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.12155249 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.11879201 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.10000357 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.95894283 |
| 26 | regulation of complement activation (GO:0030449) | 4.91024341 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.85579149 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.82434310 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.82335326 |
| 30 | protein carboxylation (GO:0018214) | 4.82335326 |
| 31 | cysteine metabolic process (GO:0006534) | 4.80310363 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.80135522 |
| 33 | regulation of triglyceride catabolic process (GO:0010896) | 4.76384622 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 4.70574051 |
| 35 | regulation of DNA endoreduplication (GO:0032875) | 4.69816532 |
| 36 | aromatic amino acid family metabolic process (GO:0009072) | 4.64706078 |
| 37 | bile acid metabolic process (GO:0008206) | 4.58281862 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.57173542 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.55256485 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.54555080 |
| 41 | * vitamin A metabolic process (GO:0006776) | 4.52747972 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.41247496 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.41247496 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.41247496 |
| 45 | phospholipid efflux (GO:0033700) | 4.37865424 |
| 46 | serine family amino acid catabolic process (GO:0009071) | 4.36850337 |
| 47 | behavioral response to nicotine (GO:0035095) | 4.35560774 |
| 48 | acylglycerol homeostasis (GO:0055090) | 4.30327721 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.30327721 |
| 50 | drug catabolic process (GO:0042737) | 4.24428237 |
| 51 | bile acid and bile salt transport (GO:0015721) | 4.22433190 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 4.17074124 |
| 53 | cholesterol efflux (GO:0033344) | 4.16790687 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.12481180 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 4.12481180 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 4.08192510 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.04388689 |
| 58 | lysine metabolic process (GO:0006553) | 4.01319426 |
| 59 | lysine catabolic process (GO:0006554) | 4.01319426 |
| 60 | retinal metabolic process (GO:0042574) | 3.98914795 |
| 61 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.94448596 |
| 62 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.94448596 |
| 63 | regulation of mesoderm development (GO:2000380) | 3.93235009 |
| 64 | cellular glucuronidation (GO:0052695) | 3.93162317 |
| 65 | ethanol oxidation (GO:0006069) | 3.88621324 |
| 66 | chromatin remodeling at centromere (GO:0031055) | 3.87848268 |
| 67 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.87347259 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 3.87088065 |
| 69 | glutamate metabolic process (GO:0006536) | 3.81757406 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 3.79908252 |
| 71 | regulation of bile acid biosynthetic process (GO:0070857) | 3.78008148 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.77895230 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.76880333 |
| 74 | plasma lipoprotein particle assembly (GO:0034377) | 3.76485354 |
| 75 | ketone body metabolic process (GO:1902224) | 3.76075349 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.75387794 |
| 77 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.74667325 |
| 78 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.74667325 |
| 79 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.74667325 |
| 80 | amine catabolic process (GO:0009310) | 3.72971038 |
| 81 | cellular biogenic amine catabolic process (GO:0042402) | 3.72971038 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 3.72118678 |
| 83 | opsonization (GO:0008228) | 3.71305725 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.71120136 |
| 85 | fibrinolysis (GO:0042730) | 3.69097914 |
| 86 | arginine metabolic process (GO:0006525) | 3.68492257 |
| 87 | phospholipid homeostasis (GO:0055091) | 3.68023470 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.64025039 |
| 89 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.63938221 |
| 90 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.63938221 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.62466699 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.61961830 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.61070114 |
| 94 | negative regulation of protein activation cascade (GO:2000258) | 3.60603879 |
| 95 | flavonoid metabolic process (GO:0009812) | 3.59950181 |
| 96 | DNA replication checkpoint (GO:0000076) | 3.59832538 |
| 97 | drug metabolic process (GO:0017144) | 3.59373919 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59190961 |
| 99 | cellular modified amino acid catabolic process (GO:0042219) | 3.57526691 |
| 100 | sterol homeostasis (GO:0055092) | 3.56491628 |
| 101 | negative regulation of telomerase activity (GO:0051974) | 3.53356621 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.52588460 |
| 103 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.50346076 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.50050489 |
| 105 | uronic acid metabolic process (GO:0006063) | 3.50050489 |
| 106 | DNA double-strand break processing (GO:0000729) | 3.49985388 |
| 107 | L-serine metabolic process (GO:0006563) | 3.49723136 |
| 108 | CENP-A containing nucleosome assembly (GO:0034080) | 3.49089289 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.48103435 |
| 110 | complement activation (GO:0006956) | 3.48028236 |
| 111 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47756727 |
| 112 | negative regulation of lipase activity (GO:0060192) | 3.47714805 |
| 113 | glycine metabolic process (GO:0006544) | 3.47047570 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 3.44724691 |
| 115 | protein activation cascade (GO:0072376) | 3.44668812 |
| 116 | serine family amino acid metabolic process (GO:0009069) | 3.42522660 |
| 117 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.41760745 |
| 118 | telomere maintenance via telomerase (GO:0007004) | 3.41514238 |
| 119 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.39452037 |
| 120 | histone exchange (GO:0043486) | 3.38170622 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.37264391 |
| 122 | protein-lipid complex assembly (GO:0065005) | 3.36683648 |
| 123 | plasma lipoprotein particle organization (GO:0071827) | 3.35633813 |
| 124 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.33834642 |
| 125 | regulation of helicase activity (GO:0051095) | 3.31050522 |
| 126 | lung-associated mesenchyme development (GO:0060484) | 3.24551803 |
| 127 | hemidesmosome assembly (GO:0031581) | 3.23519134 |
| 128 | sulfation (GO:0051923) | 3.20980924 |
| 129 | pre-miRNA processing (GO:0031054) | 3.17662509 |
| 130 | DNA strand renaturation (GO:0000733) | 3.15798248 |
| 131 | negative regulation of telomere maintenance (GO:0032205) | 3.09913348 |
| 132 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.08762798 |
| 133 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.06716364 |
| 134 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.99230633 |
| 135 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.99230633 |
| 136 | protein neddylation (GO:0045116) | 2.98068508 |
| 137 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.97217188 |
| 138 | NADH dehydrogenase complex assembly (GO:0010257) | 2.97217188 |
| 139 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.97217188 |
| 140 | replication fork processing (GO:0031297) | 2.97150846 |
| 141 | anterior/posterior axis specification, embryo (GO:0008595) | 2.96632036 |
| 142 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.95463318 |
| 143 | response to X-ray (GO:0010165) | 2.87766253 |
| 144 | kidney morphogenesis (GO:0060993) | 2.87625300 |
| 145 | regulation of meiosis I (GO:0060631) | 2.83888803 |
| 146 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.83544599 |
| 147 | chaperone-mediated protein transport (GO:0072321) | 2.83443429 |
| 148 | membrane repolarization during action potential (GO:0086011) | 2.82535469 |
| 149 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.78025785 |
| 150 | DNA replication-independent nucleosome organization (GO:0034724) | 2.77525595 |
| 151 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.77525595 |
| 152 | lateral sprouting from an epithelium (GO:0060601) | 2.76153450 |
| 153 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.75829811 |
| 154 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.75829811 |
| 155 | isotype switching (GO:0045190) | 2.75829811 |
| 156 | presynaptic membrane assembly (GO:0097105) | 2.74698357 |
| 157 | female gonad development (GO:0008585) | 2.73023384 |
| 158 | cell proliferation in forebrain (GO:0021846) | 2.71592864 |
| 159 | synapsis (GO:0007129) | 2.70988623 |
| 160 | outer ear morphogenesis (GO:0042473) | 2.70158248 |
| 161 | cellular response to electrical stimulus (GO:0071257) | 2.69969619 |
| 162 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.68374762 |
| 163 | termination of RNA polymerase III transcription (GO:0006386) | 2.68374762 |
| 164 | negative regulation of gene silencing (GO:0060969) | 2.66456592 |
| 165 | regulation of telomere maintenance (GO:0032204) | 2.65711464 |
| 166 | protein complex biogenesis (GO:0070271) | 2.65277194 |
| 167 | regulation of DNA methylation (GO:0044030) | 2.65216616 |
| 168 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.63926960 |
| 169 | IMP biosynthetic process (GO:0006188) | 2.63907016 |
| 170 | regulation of cell fate specification (GO:0042659) | 2.61792961 |
| 171 | somatic recombination of immunoglobulin gene segments (GO:0016447) | 2.61709142 |
| 172 | negative regulation of membrane potential (GO:0045837) | 2.61620403 |
| 173 | regulation of cell fate commitment (GO:0010453) | 2.60631116 |
| 174 | dorsal/ventral axis specification (GO:0009950) | 2.60170276 |
| 175 | otic vesicle formation (GO:0030916) | 2.57775818 |
| 176 | regulation of telomerase activity (GO:0051972) | 2.57569450 |
| 177 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.55161385 |
| 178 | heterochromatin organization (GO:0070828) | 2.54475331 |
| 179 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.50553120 |
| 180 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.50036757 |
| 181 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.50036757 |
| 182 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.50036757 |
| 183 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.50036757 |
| 184 | negative regulation of sister chromatid segregation (GO:0033046) | 2.50036757 |
| 185 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.49155919 |
| 186 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.49155919 |
| 187 | presynaptic membrane organization (GO:0097090) | 2.49007605 |
| 188 | regulation of gene silencing (GO:0060968) | 2.47303037 |
| 189 | ncRNA catabolic process (GO:0034661) | 2.46962822 |
| 190 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.45208296 |
| 191 | pseudouridine synthesis (GO:0001522) | 2.45061087 |
| 192 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.44922577 |
| 193 | somatic diversification of immunoglobulins (GO:0016445) | 2.44919478 |
| 194 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.39663601 |
| 195 | membrane repolarization (GO:0086009) | 2.38704535 |
| 196 | negative regulation of chromosome segregation (GO:0051985) | 2.38306853 |
| 197 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.38181456 |
| 198 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.35698907 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.80281822 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.93182889 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.88945941 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.87799525 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.57678956 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.41926254 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.14629165 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.99735636 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.50021245 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.24012011 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.90323351 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.86275206 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70175443 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.60601475 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.48259330 |
| 16 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.47520264 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.43275747 |
| 18 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.40524584 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.32596590 |
| 20 | EWS_26573619_Chip-Seq_HEK293_Human | 2.27012616 |
| 21 | FUS_26573619_Chip-Seq_HEK293_Human | 2.26053235 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.25248322 |
| 23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.14288639 |
| 24 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.14288639 |
| 25 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.14288639 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.10881032 |
| 27 | P300_19829295_ChIP-Seq_ESCs_Human | 2.10794204 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.09286778 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03094451 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.87525102 |
| 31 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.86866491 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85033083 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.80829847 |
| 34 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.80416276 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.74698341 |
| 36 | * SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.74413111 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71919395 |
| 38 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71669547 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70021361 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69580175 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67783849 |
| 42 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64551449 |
| 43 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.64451656 |
| 44 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.61385028 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60266550 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60261375 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54626081 |
| 48 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54443403 |
| 49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.53373611 |
| 50 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52829827 |
| 51 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.50405916 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.49860479 |
| 53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46492252 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46323320 |
| 55 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.45868499 |
| 56 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.45867348 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45300097 |
| 58 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43800005 |
| 59 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43800005 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43729151 |
| 61 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.42472983 |
| 62 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39469982 |
| 63 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37349266 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34051929 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32968365 |
| 66 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.32568893 |
| 67 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29550962 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29307054 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27873145 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.27740318 |
| 71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26066068 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25475347 |
| 73 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23309099 |
| 74 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22760060 |
| 75 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21276021 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.20222012 |
| 77 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.19233411 |
| 78 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.19176267 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.17549798 |
| 80 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.17127668 |
| 81 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16821548 |
| 82 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.15776478 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15445484 |
| 84 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.15021481 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14284081 |
| 86 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13581842 |
| 87 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.12925850 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11953504 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09195352 |
| 90 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.09149520 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08788651 |
| 92 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08043125 |
| 93 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07438280 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07326971 |
| 95 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.06830469 |
| 96 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06127615 |
| 97 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05488635 |
| 98 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05352571 |
| 99 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05226470 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04843318 |
| 101 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.04722249 |
| 102 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04537415 |
| 103 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04514970 |
| 104 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03776886 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03577600 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.03257633 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03191015 |
| 108 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03191015 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02550516 |
| 110 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02168065 |
| 111 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01717749 |
| 112 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01717749 |
| 113 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01618537 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01600111 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00446980 |
| 116 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.99228916 |
| 117 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.98971318 |
| 118 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98936702 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98328101 |
| 120 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98328101 |
| 121 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98146047 |
| 122 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97263797 |
| 123 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97187066 |
| 124 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96768658 |
| 125 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.96402071 |
| 126 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96254046 |
| 127 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.96150108 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95880755 |
| 129 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95686643 |
| 130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93506669 |
| 131 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.91584165 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91338447 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.90285402 |
| 134 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90015355 |
| 135 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.89677178 |
| 136 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88317995 |
| 137 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85842136 |
| 138 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.84321949 |
| 139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82975838 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80911836 |
| 141 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79443997 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78391651 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76257581 |
| 144 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.75544876 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.74888839 |
| 146 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73865507 |
| 147 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.73429740 |
| 148 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73187149 |
| 149 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71502946 |
| 150 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70259615 |
| 151 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.68437067 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.68344562 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.68099648 |
| 154 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.68042388 |
| 155 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.67874102 |
| 156 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67785411 |
| 157 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66697862 |
| 158 | CBP_21632823_ChIP-Seq_H3396_Human | 0.65941500 |
| 159 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65491692 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64712489 |
| 161 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64646370 |
| 162 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.64269658 |
| 163 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.64169837 |
| 164 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.62879303 |
| 165 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62148683 |
| 166 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.60989712 |
| 167 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60645760 |
| 168 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59969107 |
| 169 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59870312 |
| 170 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.59771759 |
| 171 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.59496717 |
| 172 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.58520943 |
| 173 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58381962 |
| 174 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.56412620 |
| 175 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56312246 |
| 176 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.56217544 |
| 177 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.56180895 |
| 178 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55617421 |
| 179 | GATA1_19941826_ChIP-Seq_K562_Human | 0.55561038 |
| 180 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52908745 |
| 181 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.52241766 |
| 182 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.51747682 |
| 183 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.50088402 |
| 184 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.50061885 |
| 185 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.49892020 |
| 186 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49715672 |
| 187 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.48809579 |
| 188 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.48803339 |
| 189 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47590634 |
| 190 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.47366273 |
| 191 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.47164369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.50687863 |
| 2 | MP0005360_urolithiasis | 7.31839056 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.88120737 |
| 4 | MP0005365_abnormal_bile_salt | 5.29940850 |
| 5 | MP0003011_delayed_dark_adaptation | 5.20533109 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02624517 |
| 7 | MP0003941_abnormal_skin_development | 4.47679429 |
| 8 | MP0003252_abnormal_bile_duct | 3.58965798 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.37536330 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.36548241 |
| 11 | MP0008877_abnormal_DNA_methylation | 3.26985949 |
| 12 | MP0006292_abnormal_olfactory_placode | 3.22320474 |
| 13 | MP0009840_abnormal_foam_cell | 3.03311416 |
| 14 | * MP0004019_abnormal_vitamin_homeostasis | 2.73341278 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.66417775 |
| 16 | MP0005083_abnormal_biliary_tract | 2.59345811 |
| 17 | MP0001188_hyperpigmentation | 2.49087262 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.45160515 |
| 19 | MP0005332_abnormal_amino_acid | 2.41727672 |
| 20 | MP0003890_abnormal_embryonic-extraembry | 2.36323535 |
| 21 | MP0001485_abnormal_pinna_reflex | 2.32783435 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 2.23632426 |
| 23 | MP0003195_calcinosis | 2.13557287 |
| 24 | MP0003718_maternal_effect | 2.13378350 |
| 25 | MP0002254_reproductive_system_inflammat | 2.07517546 |
| 26 | MP0008058_abnormal_DNA_repair | 1.96638728 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.93410951 |
| 28 | MP0000609_abnormal_liver_physiology | 1.89846182 |
| 29 | MP0002938_white_spotting | 1.86250206 |
| 30 | MP0000049_abnormal_middle_ear | 1.83793564 |
| 31 | MP0002102_abnormal_ear_morphology | 1.82917018 |
| 32 | MP0004133_heterotaxia | 1.80890431 |
| 33 | MP0003937_abnormal_limbs/digits/tail_de | 1.80575260 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.79221677 |
| 35 | MP0006072_abnormal_retinal_apoptosis | 1.78860963 |
| 36 | MP0000569_abnormal_digit_pigmentation | 1.74750082 |
| 37 | MP0001293_anophthalmia | 1.65107959 |
| 38 | MP0003119_abnormal_digestive_system | 1.61506345 |
| 39 | MP0003646_muscle_fatigue | 1.60348534 |
| 40 | MP0004885_abnormal_endolymph | 1.59359536 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.54446677 |
| 42 | MP0003868_abnormal_feces_composition | 1.51318571 |
| 43 | MP0003567_abnormal_fetal_cardiomyocyte | 1.50782675 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.49900977 |
| 45 | MP0004957_abnormal_blastocyst_morpholog | 1.48730186 |
| 46 | MP0003283_abnormal_digestive_organ | 1.46544167 |
| 47 | MP0010094_abnormal_chromosome_stability | 1.45690897 |
| 48 | MP0003787_abnormal_imprinting | 1.39236993 |
| 49 | MP0000762_abnormal_tongue_morphology | 1.39200092 |
| 50 | MP0001764_abnormal_homeostasis | 1.38310235 |
| 51 | MP0009697_abnormal_copulation | 1.36974720 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36556977 |
| 53 | MP0003121_genomic_imprinting | 1.34822627 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 1.30651543 |
| 55 | MP0005408_hypopigmentation | 1.29012857 |
| 56 | MP0008932_abnormal_embryonic_tissue | 1.28611041 |
| 57 | MP0002160_abnormal_reproductive_system | 1.28187364 |
| 58 | MP0002272_abnormal_nervous_system | 1.23255309 |
| 59 | MP0000631_abnormal_neuroendocrine_gland | 1.22130289 |
| 60 | MP0009250_abnormal_appendicular_skeleto | 1.20487147 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.19275513 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.19064943 |
| 63 | MP0000383_abnormal_hair_follicle | 1.16945335 |
| 64 | MP0009643_abnormal_urine_homeostasis | 1.16308869 |
| 65 | MP0001177_atelectasis | 1.15895214 |
| 66 | MP0001486_abnormal_startle_reflex | 1.15461988 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.13628792 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.13297345 |
| 69 | MP0009745_abnormal_behavioral_response | 1.12899990 |
| 70 | MP0004145_abnormal_muscle_electrophysio | 1.12794345 |
| 71 | MP0002736_abnormal_nociception_after | 1.11985410 |
| 72 | MP0005647_abnormal_sex_gland | 1.11676698 |
| 73 | MP0005257_abnormal_intraocular_pressure | 1.10934312 |
| 74 | MP0001984_abnormal_olfaction | 1.10317413 |
| 75 | MP0009672_abnormal_birth_weight | 1.07737068 |
| 76 | MP0002751_abnormal_autonomic_nervous | 1.07532526 |
| 77 | MP0003123_paternal_imprinting | 1.07496832 |
| 78 | MP0003755_abnormal_palate_morphology | 1.07150313 |
| 79 | MP0005451_abnormal_body_composition | 1.07051012 |
| 80 | MP0001286_abnormal_eye_development | 1.06931069 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.06389185 |
| 82 | MP0005389_reproductive_system_phenotype | 1.06151343 |
| 83 | MP0008007_abnormal_cellular_replicative | 1.06022304 |
| 84 | MP0006276_abnormal_autonomic_nervous | 1.04614593 |
| 85 | MP0009764_decreased_sensitivity_to | 1.04183307 |
| 86 | MP0000467_abnormal_esophagus_morphology | 1.03750580 |
| 87 | MP0001968_abnormal_touch/_nociception | 1.03014289 |
| 88 | MP0004215_abnormal_myocardial_fiber | 1.01710036 |
| 89 | MP0002234_abnormal_pharynx_morphology | 1.00212136 |
| 90 | MP0002233_abnormal_nose_morphology | 0.99096417 |
| 91 | MP0002697_abnormal_eye_size | 0.97455172 |
| 92 | MP0000604_amyloidosis | 0.96750397 |
| 93 | MP0003122_maternal_imprinting | 0.96226661 |
| 94 | MP0004142_abnormal_muscle_tone | 0.95284014 |
| 95 | MP0005394_taste/olfaction_phenotype | 0.94383359 |
| 96 | MP0005499_abnormal_olfactory_system | 0.94383359 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.93858036 |
| 98 | MP0003724_increased_susceptibility_to | 0.93568982 |
| 99 | MP0004742_abnormal_vestibular_system | 0.92733941 |
| 100 | MP0000598_abnormal_liver_morphology | 0.91572182 |
| 101 | MP0008057_abnormal_DNA_replication | 0.91333836 |
| 102 | MP0005377_hearing/vestibular/ear_phenot | 0.90865241 |
| 103 | MP0003878_abnormal_ear_physiology | 0.90865241 |
| 104 | MP0003656_abnormal_erythrocyte_physiolo | 0.88603911 |
| 105 | MP0005423_abnormal_somatic_nervous | 0.88410345 |
| 106 | MP0001324_abnormal_eye_pigmentation | 0.87972403 |
| 107 | MP0002184_abnormal_innervation | 0.86592863 |
| 108 | * MP0002752_abnormal_somatic_nervous | 0.86373706 |
| 109 | MP0009763_increased_sensitivity_to | 0.86023117 |
| 110 | MP0003186_abnormal_redox_activity | 0.85155153 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.84442739 |
| 112 | MP0000026_abnormal_inner_ear | 0.82410027 |
| 113 | MP0002734_abnormal_mechanical_nocicepti | 0.82284592 |
| 114 | MP0000778_abnormal_nervous_system | 0.82197852 |
| 115 | MP0008872_abnormal_physiological_respon | 0.82169163 |
| 116 | MP0001529_abnormal_vocalization | 0.81705766 |
| 117 | MP0009046_muscle_twitch | 0.80899837 |
| 118 | MP0002735_abnormal_chemical_nociception | 0.79361606 |
| 119 | MP0002837_dystrophic_cardiac_calcinosis | 0.79130412 |
| 120 | MP0002572_abnormal_emotion/affect_behav | 0.77583168 |
| 121 | MP0001963_abnormal_hearing_physiology | 0.77370336 |
| 122 | MP0008469_abnormal_protein_level | 0.76846633 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.76519333 |
| 124 | MP0001881_abnormal_mammary_gland | 0.76262283 |
| 125 | MP0002111_abnormal_tail_morphology | 0.76178820 |
| 126 | MP0004130_abnormal_muscle_cell | 0.75774081 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.75526788 |
| 128 | MP0002084_abnormal_developmental_patter | 0.75396387 |
| 129 | MP0003861_abnormal_nervous_system | 0.75363090 |
| 130 | * MP0005195_abnormal_posterior_eye | 0.74891047 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.74348197 |
| 132 | MP0002085_abnormal_embryonic_tissue | 0.73598825 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.73523074 |
| 134 | MP0010030_abnormal_orbit_morphology | 0.73431146 |
| 135 | MP0009642_abnormal_blood_homeostasis | 0.73428785 |
| 136 | MP0004197_abnormal_fetal_growth/weight/ | 0.73313221 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.72293338 |
| 138 | MP0001299_abnormal_eye_distance/ | 0.72026818 |
| 139 | MP0004381_abnormal_hair_follicle | 0.67861716 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.67747675 |
| 141 | MP0009384_cardiac_valve_regurgitation | 0.67465685 |
| 142 | MP0000579_abnormal_nail_morphology | 0.66568608 |
| 143 | MP0001661_extended_life_span | 0.66491978 |
| 144 | * MP0005551_abnormal_eye_electrophysiolog | 0.62651249 |
| 145 | MP0003690_abnormal_glial_cell | 0.61988611 |
| 146 | MP0000372_irregular_coat_pigmentation | 0.61956478 |
| 147 | MP0009765_abnormal_xenobiotic_induced | 0.60482973 |
| 148 | MP0008438_abnormal_cutaneous_collagen | 0.59839310 |
| 149 | MP0005334_abnormal_fat_pad | 0.59180540 |
| 150 | MP0002078_abnormal_glucose_homeostasis | 0.58762503 |
| 151 | MP0005275_abnormal_skin_tensile | 0.58712950 |
| 152 | MP0005084_abnormal_gallbladder_morpholo | 0.57865236 |
| 153 | MP0003329_amyloid_beta_deposits | 0.56166137 |
| 154 | MP0002971_abnormal_brown_adipose | 0.55679914 |
| 155 | MP0001756_abnormal_urination | 0.55523070 |
| 156 | MP0002796_impaired_skin_barrier | 0.55289883 |
| 157 | MP0005464_abnormal_platelet_physiology | 0.51266879 |
| 158 | MP0005535_abnormal_body_temperature | 0.49894920 |
| 159 | MP0006036_abnormal_mitochondrial_physio | 0.48795264 |
| 160 | MP0000639_abnormal_adrenal_gland | 0.48433007 |
| 161 | MP0004147_increased_porphyrin_level | 0.47924319 |
| 162 | MP0000249_abnormal_blood_vessel | 0.47797267 |
| 163 | MP0004883_abnormal_blood_vessel | 0.47539684 |
| 164 | MP0005164_abnormal_response_to | 0.47238469 |
| 165 | MP0003075_altered_response_to | 0.46924180 |
| 166 | MP0005448_abnormal_energy_balance | 0.46445817 |
| 167 | MP0002136_abnormal_kidney_physiology | 0.46280262 |
| 168 | MP0003638_abnormal_response/metabolism_ | 0.45567204 |
| 169 | MP0009053_abnormal_anal_canal | 0.44407947 |
| 170 | MP0005266_abnormal_metabolism | 0.44135543 |
| 171 | MP0006082_CNS_inflammation | 0.43476197 |
| 172 | MP0000371_diluted_coat_color | 0.43166976 |
| 173 | MP0005220_abnormal_exocrine_pancreas | 0.43059450 |
| 174 | MP0003136_yellow_coat_color | 0.42622484 |
| 175 | MP0001879_abnormal_lymphatic_vessel | 0.42283924 |
| 176 | MP0002132_abnormal_respiratory_system | 0.41166208 |
| 177 | MP0005166_decreased_susceptibility_to | 0.41140424 |
| 178 | MP0000427_abnormal_hair_cycle | 0.41121425 |
| 179 | MP0005197_abnormal_uvea_morphology | 0.40574865 |
| 180 | * MP0002090_abnormal_vision | 0.40035515 |
| 181 | MP0003453_abnormal_keratinocyte_physiol | 0.39516464 |
| 182 | MP0008874_decreased_physiological_sensi | 0.39215719 |
| 183 | MP0000230_abnormal_systemic_arterial | 0.38885314 |
| 184 | MP0005670_abnormal_white_adipose | 0.37338995 |
| 185 | MP0005248_abnormal_Harderian_gland | 0.37165607 |
| 186 | MP0005253_abnormal_eye_physiology | 0.37075136 |
| 187 | MP0005595_abnormal_vascular_smooth | 0.36347666 |
| 188 | MP0002060_abnormal_skin_morphology | 0.34549021 |
| 189 | MP0005395_other_phenotype | 0.34248470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.21174753 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.98259950 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.48234686 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.18031460 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.14917311 |
| 6 | Xanthomatosis (HP:0000991) | 5.97384952 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.93838840 |
| 8 | Complement deficiency (HP:0004431) | 5.36343075 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.11655940 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.56331200 |
| 11 | Joint hemorrhage (HP:0005261) | 4.41654834 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.33635836 |
| 13 | Epidermoid cyst (HP:0200040) | 4.32706441 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16572525 |
| 15 | Hyperammonemia (HP:0001987) | 4.15988490 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.12532640 |
| 17 | Abnormality of the labia minora (HP:0012880) | 4.10251974 |
| 18 | Fat malabsorption (HP:0002630) | 4.06984023 |
| 19 | Abnormality of complement system (HP:0005339) | 3.93236073 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.89046300 |
| 21 | Hyperglycinemia (HP:0002154) | 3.87122957 |
| 22 | Hyperglycinuria (HP:0003108) | 3.78065508 |
| 23 | Ketosis (HP:0001946) | 3.77052239 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.77034891 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75784444 |
| 26 | * Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.72914329 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.68330197 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.64715125 |
| 29 | Abnormality of glycine metabolism (HP:0010895) | 3.62778867 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62778867 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57753661 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.55999213 |
| 33 | Septo-optic dysplasia (HP:0100842) | 3.55714414 |
| 34 | Colon cancer (HP:0003003) | 3.48199091 |
| 35 | Stenosis of the external auditory canal (HP:0000402) | 3.46802147 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.43458125 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21581401 |
| 38 | Spontaneous abortion (HP:0005268) | 3.01998752 |
| 39 | Systemic lupus erythematosus (HP:0002725) | 2.98040302 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.95410216 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93485783 |
| 42 | Fragile nails (HP:0001808) | 2.92639954 |
| 43 | Steatorrhea (HP:0002570) | 2.87688731 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87097647 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.86358173 |
| 46 | Esophageal varix (HP:0002040) | 2.85379586 |
| 47 | Ketoacidosis (HP:0001993) | 2.84850262 |
| 48 | Vascular calcification (HP:0004934) | 2.84808565 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.84466502 |
| 50 | Amyloidosis (HP:0011034) | 2.80713156 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.79437973 |
| 52 | Hypochromic microcytic anemia (HP:0004840) | 2.76498299 |
| 53 | Acanthocytosis (HP:0001927) | 2.76384033 |
| 54 | Abnormality of the renal collecting system (HP:0004742) | 2.74654300 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.73697310 |
| 56 | Skin nodule (HP:0200036) | 2.72704687 |
| 57 | Mitral stenosis (HP:0001718) | 2.67902579 |
| 58 | Esophageal atresia (HP:0002032) | 2.66068226 |
| 59 | Myocardial infarction (HP:0001658) | 2.65045633 |
| 60 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.63820277 |
| 61 | Short hallux (HP:0010109) | 2.63552428 |
| 62 | Cardiovascular calcification (HP:0011915) | 2.61487187 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.60629812 |
| 64 | Decreased circulating renin level (HP:0003351) | 2.57597664 |
| 65 | Bilateral microphthalmos (HP:0007633) | 2.57475838 |
| 66 | Pancreatic fibrosis (HP:0100732) | 2.57095647 |
| 67 | Glomerulonephritis (HP:0000099) | 2.54721810 |
| 68 | True hermaphroditism (HP:0010459) | 2.53108870 |
| 69 | Metabolic acidosis (HP:0001942) | 2.49587520 |
| 70 | Malnutrition (HP:0004395) | 2.49573523 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.45789105 |
| 72 | Pendular nystagmus (HP:0012043) | 2.44529624 |
| 73 | Spastic diplegia (HP:0001264) | 2.44427882 |
| 74 | Pancreatic cysts (HP:0001737) | 2.43257191 |
| 75 | * Abolished electroretinogram (ERG) (HP:0000550) | 2.41648620 |
| 76 | Cholelithiasis (HP:0001081) | 2.41226476 |
| 77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41164938 |
| 78 | Birth length less than 3rd percentile (HP:0003561) | 2.39714503 |
| 79 | Congenital stationary night blindness (HP:0007642) | 2.39140024 |
| 80 | Milia (HP:0001056) | 2.38409112 |
| 81 | Polycythemia (HP:0001901) | 2.37559594 |
| 82 | Gout (HP:0001997) | 2.35415701 |
| 83 | Maternal diabetes (HP:0009800) | 2.32102204 |
| 84 | Hypopigmentation of the fundus (HP:0007894) | 2.32005837 |
| 85 | Congenital, generalized hypertrichosis (HP:0004540) | 2.31550502 |
| 86 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.31347515 |
| 87 | Decreased central vision (HP:0007663) | 2.30952398 |
| 88 | Nephritis (HP:0000123) | 2.29147272 |
| 89 | Lethargy (HP:0001254) | 2.25878833 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.24350211 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.24350211 |
| 92 | Hypoglycemic seizures (HP:0002173) | 2.24212608 |
| 93 | Abnormal lung lobation (HP:0002101) | 2.22437696 |
| 94 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.20756883 |
| 95 | Gingival bleeding (HP:0000225) | 2.18943910 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.18459894 |
| 97 | Cholecystitis (HP:0001082) | 2.18459894 |
| 98 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16954433 |
| 99 | Ectopic kidney (HP:0000086) | 2.13867240 |
| 100 | Thrombophlebitis (HP:0004418) | 2.13161954 |
| 101 | Irritability (HP:0000737) | 2.13015946 |
| 102 | Dicarboxylic aciduria (HP:0003215) | 2.12825198 |
| 103 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.12825198 |
| 104 | Nephronophthisis (HP:0000090) | 2.12180756 |
| 105 | Optic nerve hypoplasia (HP:0000609) | 2.09647879 |
| 106 | Abnormality of cochlea (HP:0000375) | 2.09062393 |
| 107 | Abnormality of midbrain morphology (HP:0002418) | 2.05682794 |
| 108 | Molar tooth sign on MRI (HP:0002419) | 2.05682794 |
| 109 | Pancreatitis (HP:0001733) | 2.05630669 |
| 110 | Meckel diverticulum (HP:0002245) | 2.05614339 |
| 111 | Hemorrhage of the eye (HP:0011885) | 2.05383504 |
| 112 | Menorrhagia (HP:0000132) | 2.03840855 |
| 113 | Short tibia (HP:0005736) | 2.03326011 |
| 114 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.03245940 |
| 115 | Methylmalonic acidemia (HP:0002912) | 2.03005462 |
| 116 | Absent septum pellucidum (HP:0001331) | 2.02980432 |
| 117 | Breast aplasia (HP:0100783) | 2.02832770 |
| 118 | Labial hypoplasia (HP:0000066) | 2.00389642 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 2.00299045 |
| 120 | Poikilocytosis (HP:0004447) | 2.00215925 |
| 121 | Hypoplasia of the uterus (HP:0000013) | 1.99566867 |
| 122 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.99122224 |
| 123 | Gastrointestinal atresia (HP:0002589) | 1.99119906 |
| 124 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.98951551 |
| 125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.98135526 |
| 126 | Broad-based gait (HP:0002136) | 1.97649338 |
| 127 | Abnormality of the ileum (HP:0001549) | 1.97310151 |
| 128 | Plantar hyperkeratosis (HP:0007556) | 1.96713120 |
| 129 | Hypoplastic female external genitalia (HP:0012815) | 1.96680477 |
| 130 | Onycholysis (HP:0001806) | 1.96479875 |
| 131 | Hypoplasia of the pons (HP:0012110) | 1.96212720 |
| 132 | Cerebral edema (HP:0002181) | 1.96058796 |
| 133 | Attenuation of retinal blood vessels (HP:0007843) | 1.95763987 |
| 134 | Neonatal onset (HP:0003623) | 1.95377113 |
| 135 | Pulmonary embolism (HP:0002204) | 1.93499005 |
| 136 | Patent foramen ovale (HP:0001655) | 1.92468646 |
| 137 | Chromsome breakage (HP:0040012) | 1.92393445 |
| 138 | Pigmentary retinal degeneration (HP:0001146) | 1.91301388 |
| 139 | Anophthalmia (HP:0000528) | 1.91018795 |
| 140 | Alkalosis (HP:0001948) | 1.90532249 |
| 141 | Enlarged kidneys (HP:0000105) | 1.90053078 |
| 142 | Abnormality of chromosome stability (HP:0003220) | 1.88575790 |
| 143 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.88456297 |
| 144 | Vomiting (HP:0002013) | 1.87804097 |
| 145 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.87440328 |
| 146 | Supernumerary spleens (HP:0009799) | 1.87059582 |
| 147 | Progressive cerebellar ataxia (HP:0002073) | 1.86812435 |
| 148 | Sclerocornea (HP:0000647) | 1.86737660 |
| 149 | Duodenal stenosis (HP:0100867) | 1.85956537 |
| 150 | Small intestinal stenosis (HP:0012848) | 1.85956537 |
| 151 | Morphological abnormality of the inner ear (HP:0011390) | 1.85890365 |
| 152 | Morphological abnormality of the middle ear (HP:0008609) | 1.85202308 |
| 153 | Rickets (HP:0002748) | 1.85059992 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.84679915 |
| 155 | Stroke (HP:0001297) | 1.84201487 |
| 156 | Abnormality of the pons (HP:0007361) | 1.84064790 |
| 157 | Anencephaly (HP:0002323) | 1.83870283 |
| 158 | Clumsiness (HP:0002312) | 1.83749524 |
| 159 | Small hand (HP:0200055) | 1.83301626 |
| 160 | Sensorimotor neuropathy (HP:0007141) | 1.83059389 |
| 161 | Cerebral hemorrhage (HP:0001342) | 1.83057950 |
| 162 | Progressive inability to walk (HP:0002505) | 1.82122572 |
| 163 | Neoplasm of the adrenal cortex (HP:0100641) | 1.81032449 |
| 164 | Patellar aplasia (HP:0006443) | 1.80592416 |
| 165 | Duplicated collecting system (HP:0000081) | 1.80290116 |
| 166 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79183310 |
| 167 | Genetic anticipation (HP:0003743) | 1.78816499 |
| 168 | Spontaneous hematomas (HP:0007420) | 1.78430119 |
| 169 | Abnormality of the preputium (HP:0100587) | 1.78338969 |
| 170 | Right ventricular cardiomyopathy (HP:0011663) | 1.78275702 |
| 171 | Fibular aplasia (HP:0002990) | 1.77878902 |
| 172 | Conjunctival telangiectasia (HP:0000524) | 1.77402512 |
| 173 | Generalized aminoaciduria (HP:0002909) | 1.77359634 |
| 174 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77324885 |
| 175 | Abnormality of alanine metabolism (HP:0010916) | 1.77093093 |
| 176 | Hyperalaninemia (HP:0003348) | 1.77093093 |
| 177 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77093093 |
| 178 | Ependymoma (HP:0002888) | 1.76737730 |
| 179 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.75959656 |
| 180 | Inability to walk (HP:0002540) | 1.75242691 |
| 181 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 1.75068352 |
| 182 | Abnormality of the duodenum (HP:0002246) | 1.75003553 |
| 183 | Abnormality of homocysteine metabolism (HP:0010919) | 1.74087521 |
| 184 | Homocystinuria (HP:0002156) | 1.74087521 |
| 185 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74028119 |
| 186 | Adactyly (HP:0009776) | 1.73306208 |
| 187 | Selective tooth agenesis (HP:0001592) | 1.72871727 |
| 188 | Abnormality of the renal medulla (HP:0100957) | 1.71025776 |
| 189 | Abnormal number of incisors (HP:0011064) | 1.70695404 |
| 190 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.69281322 |
| 191 | Chorioretinal atrophy (HP:0000533) | 1.68328290 |
| 192 | Methylmalonic aciduria (HP:0012120) | 1.67720466 |
| 193 | Gonadotropin excess (HP:0000837) | 1.63830398 |
| 194 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.63211807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.52259360 |
| 2 | FGFR4 | 3.91606125 |
| 3 | TNIK | 3.53891591 |
| 4 | TIE1 | 3.53789510 |
| 5 | ERN1 | 3.34588030 |
| 6 | SIK1 | 3.26203476 |
| 7 | MKNK2 | 3.10618008 |
| 8 | MST1R | 3.03985958 |
| 9 | TAF1 | 2.95859990 |
| 10 | FRK | 2.77222819 |
| 11 | ZAK | 2.77215346 |
| 12 | CDC7 | 2.73269903 |
| 13 | BUB1 | 2.71005751 |
| 14 | WNK3 | 2.60608600 |
| 15 | INSRR | 2.56427930 |
| 16 | TGFBR2 | 2.51622458 |
| 17 | VRK2 | 2.42156771 |
| 18 | MKNK1 | 2.38039314 |
| 19 | BMPR1B | 2.35250002 |
| 20 | ERBB4 | 2.35244427 |
| 21 | TTK | 2.14961602 |
| 22 | ACVR1B | 2.13469373 |
| 23 | TSSK6 | 2.11212498 |
| 24 | TAOK3 | 2.01205033 |
| 25 | PLK3 | 1.97474775 |
| 26 | PTK6 | 1.87885547 |
| 27 | TRIM28 | 1.79135772 |
| 28 | EPHA3 | 1.77854687 |
| 29 | PIK3CG | 1.77314948 |
| 30 | PDK2 | 1.66628790 |
| 31 | EPHB1 | 1.65134663 |
| 32 | DYRK2 | 1.64110955 |
| 33 | FGFR2 | 1.63960925 |
| 34 | CASK | 1.62576024 |
| 35 | GRK1 | 1.61266675 |
| 36 | ADRBK2 | 1.57511948 |
| 37 | TYK2 | 1.57025539 |
| 38 | LATS1 | 1.56978028 |
| 39 | MAP2K4 | 1.56915727 |
| 40 | MAPK11 | 1.48791003 |
| 41 | VRK1 | 1.44859881 |
| 42 | PLK4 | 1.43384477 |
| 43 | PNCK | 1.39974593 |
| 44 | PLK1 | 1.36900208 |
| 45 | CSK | 1.36578677 |
| 46 | PKN2 | 1.34682691 |
| 47 | DAPK2 | 1.33895229 |
| 48 | MET | 1.32183529 |
| 49 | EPHB2 | 1.31568135 |
| 50 | PDK3 | 1.30207050 |
| 51 | PDK4 | 1.30207050 |
| 52 | JAK1 | 1.29966826 |
| 53 | MYLK | 1.29318286 |
| 54 | STK16 | 1.26890532 |
| 55 | PIK3CA | 1.25380641 |
| 56 | BRSK2 | 1.20409695 |
| 57 | MAP3K14 | 1.15154701 |
| 58 | NLK | 1.12353907 |
| 59 | PRKCG | 1.12081379 |
| 60 | FLT3 | 1.11966757 |
| 61 | NEK9 | 1.11129143 |
| 62 | OXSR1 | 1.10464759 |
| 63 | AKT3 | 1.09746553 |
| 64 | FER | 1.09531368 |
| 65 | JAK2 | 1.06832211 |
| 66 | MAP3K7 | 1.06180213 |
| 67 | CSNK1G1 | 1.05429647 |
| 68 | STK3 | 1.03929753 |
| 69 | FGFR3 | 1.03835150 |
| 70 | WEE1 | 1.03098338 |
| 71 | PRKAA2 | 1.01824788 |
| 72 | CDK19 | 1.00793862 |
| 73 | PINK1 | 1.00773701 |
| 74 | KDR | 1.00533798 |
| 75 | TRIB3 | 0.97208746 |
| 76 | DYRK3 | 0.97021094 |
| 77 | GSK3A | 0.95155258 |
| 78 | MST4 | 0.95116463 |
| 79 | STK38L | 0.93727899 |
| 80 | TLK1 | 0.91462954 |
| 81 | EIF2AK2 | 0.91393654 |
| 82 | WNK4 | 0.88706082 |
| 83 | OBSCN | 0.87622716 |
| 84 | STK24 | 0.87115905 |
| 85 | GRK6 | 0.85615595 |
| 86 | MAPK12 | 0.85475615 |
| 87 | TBK1 | 0.81860827 |
| 88 | ERBB2 | 0.80549968 |
| 89 | MAP4K2 | 0.80507504 |
| 90 | CHEK2 | 0.80421804 |
| 91 | NME1 | 0.79537643 |
| 92 | ABL2 | 0.79376354 |
| 93 | PDPK1 | 0.78807900 |
| 94 | ATR | 0.78706427 |
| 95 | CSNK1G2 | 0.77741339 |
| 96 | PRKCE | 0.75907221 |
| 97 | NEK2 | 0.74449587 |
| 98 | PBK | 0.72950980 |
| 99 | MAP2K6 | 0.70972914 |
| 100 | PLK2 | 0.70836098 |
| 101 | PDGFRA | 0.69060059 |
| 102 | PRKCZ | 0.68981898 |
| 103 | PTK2 | 0.68667764 |
| 104 | RIPK1 | 0.68246095 |
| 105 | CAMK2G | 0.66639869 |
| 106 | MAPK15 | 0.65993671 |
| 107 | SRPK1 | 0.65878234 |
| 108 | MAPK4 | 0.65770775 |
| 109 | SGK3 | 0.65731849 |
| 110 | MAPKAPK5 | 0.62309837 |
| 111 | PRKACG | 0.61958680 |
| 112 | MAP3K3 | 0.60642545 |
| 113 | CAMK1G | 0.59550839 |
| 114 | PRKG2 | 0.59526719 |
| 115 | PDK1 | 0.59288278 |
| 116 | PRKCQ | 0.58668510 |
| 117 | MAP3K4 | 0.58088948 |
| 118 | MAP3K2 | 0.57494728 |
| 119 | IKBKE | 0.57305174 |
| 120 | CSNK1G3 | 0.57209091 |
| 121 | GRK5 | 0.56776125 |
| 122 | IGF1R | 0.56457132 |
| 123 | ADRBK1 | 0.54277141 |
| 124 | ATM | 0.53978494 |
| 125 | FGFR1 | 0.53005443 |
| 126 | STK39 | 0.52802589 |
| 127 | EIF2AK3 | 0.52623075 |
| 128 | MAPK7 | 0.52200359 |
| 129 | PTK2B | 0.51639889 |
| 130 | CSNK1A1L | 0.50238658 |
| 131 | CSNK1A1 | 0.49859120 |
| 132 | NEK1 | 0.49787186 |
| 133 | CDK6 | 0.48762934 |
| 134 | TGFBR1 | 0.48726901 |
| 135 | BRAF | 0.48494607 |
| 136 | PKN1 | 0.48088254 |
| 137 | PRKAA1 | 0.47707520 |
| 138 | CAMK1D | 0.47428439 |
| 139 | ALK | 0.46954481 |
| 140 | DMPK | 0.46732048 |
| 141 | MAP3K9 | 0.45625400 |
| 142 | SGK2 | 0.45416020 |
| 143 | EPHA2 | 0.45396245 |
| 144 | NUAK1 | 0.45357042 |
| 145 | PDGFRB | 0.45199886 |
| 146 | PRKACA | 0.44197506 |
| 147 | CSNK1E | 0.44066285 |
| 148 | LMTK2 | 0.43991255 |
| 149 | PRKDC | 0.43441658 |
| 150 | CSF1R | 0.43387921 |
| 151 | WNK1 | 0.43113961 |
| 152 | DYRK1B | 0.42406148 |
| 153 | CSNK2A1 | 0.42277689 |
| 154 | RPS6KA2 | 0.42085814 |
| 155 | PASK | 0.42043145 |
| 156 | SGK494 | 0.41457768 |
| 157 | SGK223 | 0.41457768 |
| 158 | RET | 0.41451102 |
| 159 | IRAK3 | 0.41162096 |
| 160 | RPS6KA6 | 0.40578748 |
| 161 | AURKB | 0.40068414 |
| 162 | EGFR | 0.38940875 |
| 163 | KIT | 0.38788727 |
| 164 | TAOK2 | 0.38723901 |
| 165 | AURKA | 0.38154079 |
| 166 | MAP2K1 | 0.38018710 |
| 167 | STK11 | 0.37967101 |
| 168 | CAMK2A | 0.37680826 |
| 169 | ICK | 0.37368610 |
| 170 | DDR2 | 0.36736089 |
| 171 | DYRK1A | 0.36075157 |
| 172 | PRKCI | 0.35843596 |
| 173 | MAPK13 | 0.35282619 |
| 174 | TEC | 0.35280415 |
| 175 | CDK3 | 0.35156635 |
| 176 | PRKCA | 0.31500926 |
| 177 | MAP2K3 | 0.30976349 |
| 178 | BMX | 0.30178893 |
| 179 | MAP3K1 | 0.29244320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16732296 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62241643 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22941704 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20859203 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89005137 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70771048 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70337239 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62143891 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47426856 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.46385041 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.41340852 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.37494717 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.31739269 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30431494 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30066394 |
| 16 | Mismatch repair_Homo sapiens_hsa03430 | 2.29335127 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 2.28007075 |
| 18 | Protein export_Homo sapiens_hsa03060 | 2.24781327 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20851215 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.18984587 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 2.18733454 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15929659 |
| 23 | * Retinol metabolism_Homo sapiens_hsa00830 | 2.15233705 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.07003858 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05185074 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.96485487 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.96121896 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.96041376 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.94973761 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94805346 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91713302 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88479909 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.86285097 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84556295 |
| 35 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.84362849 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79566363 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78684684 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76069402 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.75384941 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.73512900 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.71430205 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.70734020 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.64491233 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.63609470 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59735960 |
| 46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.59557529 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.57354512 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54353895 |
| 49 | Ribosome_Homo sapiens_hsa03010 | 1.50910505 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50442159 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.48499439 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47603215 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.44546088 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37955583 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37005266 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.36663866 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31740886 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31598697 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.31069281 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30677991 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27564668 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.27165300 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.21253740 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20751950 |
| 65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19473212 |
| 66 | Cell cycle_Homo sapiens_hsa04110 | 1.17382911 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16257952 |
| 68 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14677174 |
| 69 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.10011050 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.06381923 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 1.06170760 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05027661 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 1.04961421 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04082306 |
| 75 | * Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03070277 |
| 76 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02536354 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01540357 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.00200746 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.99220119 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.99174847 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97667353 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95838024 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95075928 |
| 84 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.93195922 |
| 85 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93096694 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91443691 |
| 87 | Spliceosome_Homo sapiens_hsa03040 | 0.90548999 |
| 88 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89666322 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89022358 |
| 90 | Purine metabolism_Homo sapiens_hsa00230 | 0.88913943 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.88653767 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.88442448 |
| 93 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.84224883 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83834448 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.83712421 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82095817 |
| 97 | Morphine addiction_Homo sapiens_hsa05032 | 0.81024050 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80930871 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79048929 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76044457 |
| 101 | Circadian entrainment_Homo sapiens_hsa04713 | 0.74427438 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74292306 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72476717 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72158894 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.71263084 |
| 106 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70950469 |
| 107 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69817995 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68199349 |
| 109 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67099176 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62509413 |
| 111 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62411388 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.58750803 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.57850267 |
| 114 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53449820 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51148775 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.48482090 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45795281 |
| 118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43921253 |
| 119 | Melanoma_Homo sapiens_hsa05218 | 0.43892029 |
| 120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40867558 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40581562 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34027317 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.29474175 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24844447 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.22934493 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22754054 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.19632060 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18595857 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.15545065 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12306033 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.05336271 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04376623 |
| 133 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03929811 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.01411232 |
| 135 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1557037 |
| 136 | Lysosome_Homo sapiens_hsa04142 | -0.1549608 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1515983 |
| 138 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1478511 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1443878 |
| 140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1411141 |
| 141 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1340494 |
| 142 | Malaria_Homo sapiens_hsa05144 | -0.1215060 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | -0.1205119 |
| 144 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0923620 |
| 145 | Pertussis_Homo sapiens_hsa05133 | -0.0756820 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0600250 |
| 147 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0568021 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | -0.0543145 |
| 149 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0417833 |
| 150 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0386775 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0256741 |
| 152 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0001103 |

